FR2814956B1 - Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation - Google Patents

Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation

Info

Publication number
FR2814956B1
FR2814956B1 FR0012817A FR0012817A FR2814956B1 FR 2814956 B1 FR2814956 B1 FR 2814956B1 FR 0012817 A FR0012817 A FR 0012817A FR 0012817 A FR0012817 A FR 0012817A FR 2814956 B1 FR2814956 B1 FR 2814956B1
Authority
FR
France
Prior art keywords
composition
injectal
preservation
human
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0012817A
Other languages
English (en)
Other versions
FR2814956A1 (fr
Inventor
Paul Barnett
Vincent Ganne
Jerome Aucouturier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Original Assignee
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA filed Critical Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority to FR0012817A priority Critical patent/FR2814956B1/fr
Priority to EP01203557A priority patent/EP1201251B1/fr
Priority to ES01203557T priority patent/ES2277887T3/es
Priority to DE60125007T priority patent/DE60125007T2/de
Priority to BR0104342-0A priority patent/BR0104342A/pt
Priority to JP2001308473A priority patent/JP4316174B2/ja
Priority to US09/972,841 priority patent/US6669947B2/en
Publication of FR2814956A1 publication Critical patent/FR2814956A1/fr
Application granted granted Critical
Publication of FR2814956B1 publication Critical patent/FR2814956B1/fr
Priority to US10/628,414 priority patent/US7807169B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
FR0012817A 2000-10-06 2000-10-06 Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation Expired - Fee Related FR2814956B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0012817A FR2814956B1 (fr) 2000-10-06 2000-10-06 Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation
ES01203557T ES2277887T3 (es) 2000-10-06 2001-09-19 Vacunas estratificadas y criogenicamente almacenadas, proceso para su preparacion.
DE60125007T DE60125007T2 (de) 2000-10-06 2001-09-19 Schichtförmige und kryogenisch gelagerte Impstoffe und Verfahren zur deren Bereitung
EP01203557A EP1201251B1 (fr) 2000-10-06 2001-09-19 Vaccins stratifiés et conservés cryogéniquement et procédé pour leur préparation
BR0104342-0A BR0104342A (pt) 2000-10-06 2001-09-28 Vacinas estratificadas e criogenicamente armazenadas e processo para preparação das mesmas
JP2001308473A JP4316174B2 (ja) 2000-10-06 2001-10-04 層状化して冷凍貯蔵したワクチン、それらを調製するための方法
US09/972,841 US6669947B2 (en) 2000-10-06 2001-10-09 Stratified and cryogenically stored vaccines, process for their preparation
US10/628,414 US7807169B2 (en) 2000-10-06 2003-07-29 Stratified and cryogenically stored vaccines, process for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0012817A FR2814956B1 (fr) 2000-10-06 2000-10-06 Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation

Publications (2)

Publication Number Publication Date
FR2814956A1 FR2814956A1 (fr) 2002-04-12
FR2814956B1 true FR2814956B1 (fr) 2003-01-24

Family

ID=8855090

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0012817A Expired - Fee Related FR2814956B1 (fr) 2000-10-06 2000-10-06 Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation

Country Status (7)

Country Link
US (2) US6669947B2 (fr)
EP (1) EP1201251B1 (fr)
JP (1) JP4316174B2 (fr)
BR (1) BR0104342A (fr)
DE (1) DE60125007T2 (fr)
ES (1) ES2277887T3 (fr)
FR (1) FR2814956B1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060228369A1 (en) * 2005-04-11 2006-10-12 Program For Appropriate Technology In Health Stabilization and preservation of temperature-sensitive vaccines
TWI527598B (zh) 2009-05-18 2016-04-01 英特威特國際股份有限公司 將致免疫組成物維持可供投與動物的方法
US20120070459A1 (en) * 2010-09-22 2012-03-22 Goovaerts Daniel G E Method for keeping a foot-and-mouth disease vaccine available for emergency vaccination
US9359627B2 (en) 2011-03-17 2016-06-07 National University Corporation Mie University Antibody production method

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3269905A (en) * 1955-03-02 1966-08-30 Charles W Damaskus Dry stratiform products and methods of producing same
US3290348A (en) * 1963-04-25 1966-12-06 Shell Oil Co Cobalt (omicron) complexes of phosphorus esters
GB1130743A (en) * 1965-06-11 1968-10-16 Ici Ltd Organo-iridium complexes
US4645849A (en) * 1985-01-22 1987-02-24 General Electric Company Hydrogenation of unsaturated hydrocarbons with cyclometallated transition metal catalysts
FR2649012B1 (fr) * 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
JP3149181B2 (ja) 1990-08-08 2001-03-26 エクソン ケミカル パテンツ インコーポレイテッド 発泡性造形品の製造方法
FR2700957B1 (fr) * 1993-01-29 1995-03-03 Seppic Sa Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation.
CA2168656C (fr) * 1993-08-06 2007-09-18 Yechezkel Barenholz Methode de preparation de vesicules chargees de structures biologiques, de biopolymeres et (ou) d'oligomeres
FR2717694B1 (fr) * 1994-03-22 1996-05-03 Seppic Sa Une composition comprenant un plasmide recombinant et ses utilisations comme vaccin et médicament.
US6117432A (en) 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2754715B1 (fr) * 1996-10-18 1998-11-13 Seppic Sa Adjuvant, notamment sous forme d'une emulsion contenant un cation metallique trivalent et composition vaccinale le comprenant
FR2733151B1 (fr) 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
DE69920915T2 (de) * 1998-07-14 2006-02-16 Wyeth Holdings Corp. Monophosphoryllipid a enthaltende adjuvans- und impfstoffzusammensetzungen
WO2001045670A2 (fr) * 1999-12-23 2001-06-28 Aphton Corporation Composition immunogenique stable destinee a etre stockee congelee

Also Published As

Publication number Publication date
EP1201251B1 (fr) 2006-12-06
EP1201251A1 (fr) 2002-05-02
ES2277887T3 (es) 2007-08-01
US7807169B2 (en) 2010-10-05
DE60125007D1 (de) 2007-01-18
JP2002121151A (ja) 2002-04-23
US20020090375A1 (en) 2002-07-11
JP4316174B2 (ja) 2009-08-19
FR2814956A1 (fr) 2002-04-12
BR0104342A (pt) 2002-05-28
US20040022798A1 (en) 2004-02-05
DE60125007T2 (de) 2007-07-05
US6669947B2 (en) 2003-12-30

Similar Documents

Publication Publication Date Title
EE05086B1 (et) Primidiini derivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod, kombinatsioon ning saadus
HUP0302114A2 (hu) Eritropoietin-fehérjét tartalmazó folyékony gyógyászati készítmény, eljárás előállítására és alkalmazása
FR15C0008I2 (fr) Derive de benzoylpyridine ou sel de ce derive, fongicide le renfermant comme ingredient actif, son procede de production, et produit intermediaire pour sa production
FR2780728B1 (fr) Sel de paroxetine nouveau, procede pour sa preparation et compositions pharmaceutiques le contenant
HUP9801234A2 (hu) Nitroglicerint tartalmazó, vizes alapú, helyileg alkalmazható krém, eljárás előállítására és alkalmazása
ATE364385T1 (de) Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer
ATE345129T1 (de) Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer
ATE370948T1 (de) Hydroxynaphthyridinoncarbonsäureamide, die sich als inhibitoren der hiv-integrase eignen
HUP0400992A3 (en) Carboxylic acid substituted oxazole derivatives, process for their preparation and their use as ppar-alpha and-gamma activators for the manufacture of pharmaceutical compositions in the treatment of diabetes
EE04590B1 (et) Respiratoorse süntsütiaalviiruse replikatsiooni inhibiitorid, nende kasutamine ja valmistamismeetod, farmatseutiline kompositsioon ja selle valmistamismeetod ning produkt
BR0114576A (pt) Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto
EE200200655A (et) 5-kloro-3-(4-metaansulfonüülfenüül)-6'-metüül[2,3']bipüridinüüli polümorfne vorm, selle valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
FR2814946B1 (fr) Composition de coloration, procede d'obtention et utilisation pour la coloration de la peau et/ou des matieres keratiniques
WO2002040702A3 (fr) Methodes de traitement du cancer et d'autres maladies et procedes permettant de developper ces methodes
NO20073437L (no) Innretning og fremgangsmate for identifisering og behandling av vaginale sykdommer
IL174206A0 (en) Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
WO2003035049A3 (fr) Utilisation d'inhibiteurs de c-kit puissants selectifs et non toxiques pour traiter des infections bacteriennes
FR2814956B1 (fr) Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation
FR2804286B1 (fr) Utilisation de derives de polyaminoacides comme agents conservateurs, compositions les comprenant et procede de conservation les utilisant
MX9806188A (es) Derivados de acidos benzofurano-acrilicos y su utilizacion como moduladores de los receptores rxrs o rars.
FR2838641B1 (fr) Composition cosmetique, procede de traitement cosmetique et preparation d'une composition pour favoriser la pousse et/ou empecher ou retarder la chute des cheveux
DK1232173T3 (da) Nye fusidinsyrederivater
FI990736A (fi) Suoja- tai säilöntäainekoostumus, sen valmistusmenetelmä sekä sen käyttö
MA24239A1 (fr) Melange comprenant de la virginiamycine, procede pour sa preparation et traitement de denrees avec ce melange
DE60100080D1 (de) Derivate von Aryl- oder Heteroaryl-Quinolinylphosphonsäuren, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100630